Tag Archives: health

BIO Principles Put Patients First

Greenwood_Jim_BTN

Patient advocacy organizations play an indispensable role in the biopharmaceutical development process: They help scientists and researchers better understand what it’s like to live with the diseases they’re trying to cure. That’s why BIO and our member companies are deeply committed to meaningful partnerships with patient advocacy organizations as we work to discover new medications to help patients live longer, healthier, more fulfilling lives. Today, there are more than 250 biotechnology health care medications and Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

WSJ: A Piece of the Immunotherapy Puzzle Solved

Just two weeks ago, the New York Times published a series of articles deeming immunotherapy as the future for cancer advances and new life-saving treatments – even though it’s not entirely clear why only some patients have success with the treatments. This week, the Wall Street Journal joined the immunotherapy conversation by highlighting two researchers who may have unlocked part of the mystery as to why only some patients benefit from immunotherapy. When Dr. Michael Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

What We’re Reading at GMO Answers

GMO-Fish-and-Tomato-2015

Each month, GMO Answers compiles a few of our favorite news stories into one post on the GMO Answers website.  This post can cover a wide variety of topics related to agriculture and biotechnology, ranging from global hunger and climate change, to genetically modified insulin and the marketing of foods. This month’s post uses the Zika outbreak in Brazil as a jumping off point, and finishes up with a nice profile of Dr. Calestous Juma Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , , , , ,

The Washington Post Unfairly Attacks The Orphan Drug Act

Greenwood_Jim_BTN

The Orphan Drug Act has been a tremendous success and addressed a market failure by providing incentives to bring new treatments to those suffering with rare diseases. That’s why I was deeply troubled by Friday’s unfair article in The Washington Post targeting the Orphan Drug Act through selective and unsubstantiated attacks that seem designed to undermine this bipartisan and hugely successful regime that has helped so many patients with rare diseases live longer and healthier Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

BIO Releases Points to Consider on Truthful and Non-Misleading Product Communication

medical_research

Today, BIO releases Points to Consider on Truthful and Non-Misleading Product Communication. This document advances the dialogue on this issue toward achieving the shared aim of getting the right medicine to the right patient at the right time. The current “Information Age” holds significant promise to improve the ability of stakeholders to make well-informed healthcare decisions.  Never before has information about healthcare interventions, including innovative medicines, been so readily available from so many different sources and through Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , ,